Join the COVID-19 group to help and get support from people like you.
COVID-19 News (Page 14)
Related terms: 2019-nCoV, 2019 Novel Coronavirus, Coronavirus, SARS-CoV-2 Infection, Novel Coronavirus Pneumonia
Cases of COVID-19 in Those With Epilepsy Low Early in the Pandemic
THURSDAY, Sept. 19, 2024 – On a global scale, people with epilepsy reported low rates of COVID-19 early in the pandemic, according to a study published online Sept. 3 in Epilepsia Open. Michael J....
Mild Initial Clinical Course Seen for COVID-19 Vaccine-Linked Myocarditis
THURSDAY, Sept. 19, 2024 – COVID-19 vaccine-associated myocarditis (C-VAM) has a mild initial clinical course, but myocardial injury is common, according to a study published online in the October...
Metformin Use Tied to Lower Incidence of Death, Long COVID After COVID-19
THURSDAY, Sept. 19, 2024 – After severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, prevalent metformin use is associated with a slightly lower incidence of death or postacute...
Diabetes Med Metformin Could Cut Risks for Long COVID
THURSDAY, Sept. 19, 2024 – One of the most common diabetes drugs, metformin, might deliver an added bonus: Lowering users' odds for Long COVID. Long COVID can present with symptoms including chronic...
Expert Advice on Preparing for the Fall COVID, Flu Season
MONDAY, Sept. 16, 2024 – People should prepare for the fall cold and flu season by getting the updated influenza and COVID-19 vaccinations, an infectious diseases expert says. “When my patients ask m...
Many Americans Wary of Vaccines as Fall Flu, COVID Season Looms: Survey
THURSDAY, Sept. 12, 2024 – A lot of Americans are on the fence regarding annual flu and COVID shots, a new survey finds. More than one-third of those polled (37%) said they’d gotten vaccines in the p...
Pandemic Isolation May Have Caused Rapid Brain Aging in Teen Girls
TUESDAY, Sept. 10, 2024 – New research uncovers a possible reason why teenaged girls struggled so mightily with their mental health during the pandemic: Scans showed their brains aged far faster...
Caseload Strain Linked to Patient Survival During Delta Wave of COVID-19
TUESDAY, Sept. 10, 2024 – Across hospital types, there is a comparably detrimental relationship between COVID-19 caseload and patient survival, according to a study published online Sept. 10 in the...
Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.
GAITHERSBURG, Md., Aug. 30, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced the Novavax COVID-19 Vac...
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine Targeting KP.2 Variant of SARS-CoV-2
CAMBRIDGE, MA / ACCESSWIRE / AUGUST 22, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application...
Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
NEW YORK & MAINZ, Germany--(BUSINESS WIRE) August 22, 2024 – Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that the U.S. Food and Drug Administration (“...
FDA Medwatch Alert: FDA Safety Communication: Do Not Use Cue Health’s COVID-19 Tests Due to Risk of False Results
May 13, 2024 – The U.S. Food and Drug Administration (FDA) is warning home test users, caregivers, and health care providers not to use Cue Health’s COVID-19 Tests for Home and Over-the-Counter (...
Invivyd Announces FDA Authorization for Emergency Use of Pemgarda (Formerly VYD222) for Pre-Exposure Prophylaxis (PrEP) of COVID-19
WALTHAM, Mass., March 22, 2024 (GLOBE NEWSWIRE) – Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company on a mission to protect the vulnerable from serious viral infectious diseases, today...
FDA Medwatch Alert: Important Information About the Correct Dosage and Administration of Moderna COVID-19 Vaccine (2023-2024 Formula) for Individuals 6 Months Through 11 Years of Age
November 1, 2023 – The Food and Drug Administration (FDA) is advising healthcare providers who administer the Moderna COVID-19 Vaccine (2023-2024 Formula) to individuals 6 months through 11 years of...
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine
Clinical data show robust immune responses across multiple circulating variants, including EG.5, FL.1.5.1, and BA.2.86 Updated vaccine to be available in pharmacies and care settings across the U.S....